KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Amortization - Intangibles (2016 - 2025)

Boston Scientific (BSX) has disclosed Amortization - Intangibles for 17 consecutive years, with $228.0 million as the latest value for Q4 2025.

  • Quarterly Amortization - Intangibles rose 1.33% to $228.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $897.0 million through Dec 2025, up 4.67% year-over-year, with the annual reading at $897.0 million for FY2025, 4.79% up from the prior year.
  • Amortization - Intangibles hit $228.0 million in Q4 2025 for Boston Scientific, up from $225.0 million in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $228.0 million in Q4 2025 to a low of $180.0 million in Q2 2021.
  • Historically, Amortization - Intangibles has averaged $206.4 million across 5 years, with a median of $206.5 million in 2023.
  • Biggest five-year swings in Amortization - Intangibles: dropped 8.63% in 2021 and later grew 13.33% in 2022.
  • Year by year, Amortization - Intangibles stood at $192.0 million in 2021, then grew by 3.65% to $199.0 million in 2022, then increased by 4.52% to $208.0 million in 2023, then rose by 8.17% to $225.0 million in 2024, then grew by 1.33% to $228.0 million in 2025.
  • Business Quant data shows Amortization - Intangibles for BSX at $228.0 million in Q4 2025, $225.0 million in Q3 2025, and $225.0 million in Q2 2025.